Clarinex

Product NDC: 0085-1334
11-digit product format: 000851334
Labeler code: 0085
Product ID: 0085-1334_22ffac95-2fe0-47f7-96c4-1d16f396cb5e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Desloratadine
Dosage form: SOLUTION
Route: ORAL
Labeler: Merck Sharp & Dohme Corp.
Application: NDA021300
Marketing category: NDA
Marketing start: 2004-09-01
Marketing end: 0000-00-00
Substance: DESLORATADINE
Active strength: 1 mg/mL
Pharmacologic classes: Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0085-1334		D	Discontinued by firm	2026-08-17
excluded package	package	0085-1334	0085-1334-01	D	Discontinued by firm	2026-08-17
excluded package	package	0085-1334	0085-1334-02	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0085-1334-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0085-1334-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0085-1334-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0085-1334-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0085-1334-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0085-1334-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0085-1334-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0085-1334-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0085-1334-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0085-1334-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0085-1334-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0085-1334-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0085-1334-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0085-1334-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0085-1334-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0085-1334-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0085-1334-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0085-1334-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0085-1334-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0085-1334-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0085-1334-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0085-1334-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0085-1334-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0085-1334-02	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021300-001	CLARINEX	DESLORATADINE	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL		RLD	2004-09-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL		RLD	2004-09-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL		RLD	2004-09-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL	AA	RLD, RS	2004-09-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL		RLD	2004-09-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL		RLD	2004-09-01	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL		RLD	2004-09-01	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL		RLD	2004-09-01	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL	AA	RLD, RS	2004-09-01	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL	AA	RLD, RS	2004-09-01	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL	AA	RLD, RS	2004-09-01	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL	AA	RLD, RS	2004-09-01	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021300-001	CLARINEX	0.5MG/ML	SOLUTION / ORAL	AA	RLD, RS	2004-09-01	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021300-001	CLARINEX	0.5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / ORAL		RLD	2004-09-01	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021300-001	AA	1	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N021300-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021300-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021300-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021300-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021300-001	AA	1	`ea99ee380514…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0085-1334-01	ML - Milliliter	0085-1334	af790547-4604-4d0b-8e35-aaa612a18067	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Desloratadine	ACTIVE INGREDIENT	FVF865388R	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
Desloratadine	ACTIVE MOIETY	FVF865388R	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
Aluminum Oxide	INACTIVE INGREDIENT	LMI26O6933	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
anhydrous citric acid	INACTIVE INGREDIENT	XF417D3PSL	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
calcium phosphate, dibasic, dihydrate	INACTIVE INGREDIENT	O7TSZ97GEP	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
edetate disodium	INACTIVE INGREDIENT	7FLD91C86K	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
FD&C Blue No. 2	INACTIVE INGREDIENT	L06K8R7DQK	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
FD&C Yellow No. 6	INACTIVE INGREDIENT	H77VEI93A8	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
polyethylene glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
propylene glycol	INACTIVE INGREDIENT	6DC9Q167V3	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
sodium benzoate	INACTIVE INGREDIENT	OJ245FE5EU	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
sorbitol	INACTIVE INGREDIENT	506T60A25R	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
starch, corn	INACTIVE INGREDIENT	O8232NY3SJ	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
talc	INACTIVE INGREDIENT	7SEV7J4R1U	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
trisodium citrate dihydrate	INACTIVE INGREDIENT	B22547B95K	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
water	INACTIVE INGREDIENT	059QF0KO0R	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14
white wax	INACTIVE INGREDIENT	7G1J5DA97F	CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.]	14